Evidence map›Paper›PMID 22430255›Full record

ReviewBiochimica et biophysica acta2012

γ-H2AX and other histone post-translational modifications in the clinic.

Christophe E Redon, Urbain Weyemi, Palak R Parekh, Dejun Huang, Allison S Burrell, William M Bonner

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Establishment ofHeliyon · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. DNA double-strand break repair in cancer: A path to achieving precision medicine.International review of cell and molecular biology · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Christophe E RedonLaboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Urbain Weyemi
Palak R Parekh
Dejun Huang
Allison S Burrell
William M Bonner
National Cancer Institute · USCenter for Cancer Research · US

Funding

Studies of Histone Functions in Chromatin; H2AX and DNA DSBsZIABC006140 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BONNER, WILLIAM · 2009 to 2015
$7.8M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC006140NCI NIH HHS Y99 CA999999
6 · The paper itself

Abstract

Chromatin is a dynamic complex of DNA and proteins that regulates the flow of information from genome to end product. The efficient recognition and faithful repair of DNA damage, particularly double-strand damage, is essential for genomic stability and cellular homeostasis. Imperfect repair of DNA double-strand breaks (DSBs) can lead to oncogenesis. The efficient repair of DSBs relies in part on the rapid formation of foci of phosphorylated histone H2AX (γ-H2AX) at each break site, and the subsequent recruitment of repair factors. These foci can be visualized with appropriate antibodies, enabling low levels of DSB damage to be measured in samples obtained from patients. Such measurements are proving useful to optimize treatments involving ionizing radiation, to assay in vivo the efficiency of various drugs to induce DNA damage, and to help diagnose patients with a variety of syndromes involving elevated levels of γ-H2AX. We will survey the state of the art of utilizing γ-H2AX in clinical settings. We will also discuss possibilities with other histone post-translational modifications. The ability to measure in vivo the responses of individual patients to particular drugs and/or radiation may help optimize treatments and improve patient care. This article is part of a Special Issue entitled: Chromatin in time and space.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAnimalsAntineoplastic AgentsBiomarkers, TumorChromatinDNA Breaks, Double-StrandedDose-Response Relationship, RadiationHistonesHumansMolecular Sequence DataNeoplasmsProtein Structure, TertiaryAntineoplastic AgentsBiomarkers, TumorChromatinH2AX protein, humanHistones

Identifiers

PMID22430255
PMCPMC3371125
OpenAlexW1971096822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.